Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifton E Barry

Showing results (81-90 of 264) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|July 20, 2005
In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolatesAmy K Barczak, Pilar Domenech, Helena I M Boshoff, et al.
Bioorganic & Medicinal Chemistry|January 11, 2026
Structure-activity relationship study of a new class of 2-amino-3,4-dihydroquinazolines as antitubercular agentsLena Trifonov, Helena I Boshoff, Jose Santinni O Roma, et al.
Plos One|May 5, 2015
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside ResistanceSandy S Roh, Laura E Smith, Jong Seok Lee, et al.
The Journal of Biological Chemistry|July 13, 2004
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of actionHelena I M Boshoff, Timothy G Myers, Brent R Copp, et al.
Medchemcomm|March 25, 2017
SAR and identification of 2-(quinolin-4-yloxy)acetamides as <i>Mycobacterium tuberculosis</i> cytochrome <i>bc</i><sub>1</sub> inhibitorsNarisa Phummarin, Helena I Boshoff, Patricia S Tsang, et al.
Nature|September 3, 2004
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune responseMichael B Reed, Pilar Domenech, Claudia Manca, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular AgentsVeena D Yadav, Helena I Boshoff, Lena Trifonov, et al.
Science (New York, N.Y.)|August 13, 2011
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosisWanliang Shi, Xuelian Zhang, Xin Jiang, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivoKathleen England, Helena I M Boshoff, Kriti Arora, et al.
Molecular Microbiology|August 22, 2012
Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosisPradeep Kumar, Kriti Arora, John R Lloyd, et al.
Pageof 27

Showing results (81-90 of 264) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|July 20, 2005
In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolatesAmy K Barczak, Pilar Domenech, Helena I M Boshoff, et al.
Bioorganic & Medicinal Chemistry|January 11, 2026
Structure-activity relationship study of a new class of 2-amino-3,4-dihydroquinazolines as antitubercular agentsLena Trifonov, Helena I Boshoff, Jose Santinni O Roma, et al.
Plos One|May 5, 2015
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside ResistanceSandy S Roh, Laura E Smith, Jong Seok Lee, et al.
The Journal of Biological Chemistry|July 13, 2004
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of actionHelena I M Boshoff, Timothy G Myers, Brent R Copp, et al.
Medchemcomm|March 25, 2017
SAR and identification of 2-(quinolin-4-yloxy)acetamides as <i>Mycobacterium tuberculosis</i> cytochrome <i>bc</i><sub>1</sub> inhibitorsNarisa Phummarin, Helena I Boshoff, Patricia S Tsang, et al.
Nature|September 3, 2004
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune responseMichael B Reed, Pilar Domenech, Claudia Manca, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular AgentsVeena D Yadav, Helena I Boshoff, Lena Trifonov, et al.
Science (New York, N.Y.)|August 13, 2011
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosisWanliang Shi, Xuelian Zhang, Xin Jiang, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivoKathleen England, Helena I M Boshoff, Kriti Arora, et al.
Molecular Microbiology|August 22, 2012
Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosisPradeep Kumar, Kriti Arora, John R Lloyd, et al.
Pageof 27